blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1693069

EP1693069 - REMEDY FOR SOLID TUMOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.05.2014
Database last updated on 04.06.2024
Most recent event   Tooltip24.07.2015Lapse of the patent in a contracting state
New state(s): BG, HU, LU		published on 26.08.2015  [2015/35]
Applicant(s)For all designated states
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome, Kita-ku
Tokyo, 115-8543 / JP
[2006/34]
Inventor(s)01 / Kawai, Shigeto
Chugai Seiyaku Kabushiki Kaisha
200, Kajiwara
Kamakura-shi, Kanagawa 2478530 / JP
02 / Mihara, Masahiko
Chugai Seiyaku Kabushiki Kaisha
1-135, Komakado
Gotenba-shi, Shizuoka 4128513 / JP
03 / Koishihara, Yasuo, c/o Chugai Seiyaku Kabushiki K.
1-1 Nihonbashi-Muromachi 2- Chome
Chuo-ku
Tokyo 103-8324 / JP
 [2013/30]
Former [2007/16]01 / Kawai, Shigeto
Chugai Seiyaku Kabushiki Kaisha, 200, Kajiwara
Kamakura-shi, Kanagawa 2478530 / JP
02 / Mihara, Masahiko
Chugai Seiyaku Kabushiki Kaisha, 1-135, Komakado
Gotenba-shi, Shizuoka 4128513 / JP
03 / Koishihara, Yasuo, c/o Chugai Seiyaku Kabushiki K.
1-1 Nihonbashi-Muromachi 2- Chome, Chuo-ku
Tokyo 103-8324 / JP
Former [2006/34]01 / Kawai, Shigeto
Chugai Seiyaku Kabushiki Kaisha, 200, Kajiwara
Kamakura-shi, Kanagawa 2478530 / JP
02 / Mihara, Masahiko
Chugai Seiyaku Kabushiki Kaisha, 1-135, Komakado
Gotenba-shi, Shizuoka 4128513 / JP
03 / Koishihara, Yasuo
Chugai Seiyaku Kabushiki Kaisha, 2-1-9, Kyobashi
Chuo-ku, Tokyo 1048301 / JP
Representative(s)Harding, Charles Thomas
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2013/30]Harding, Charles Thomas
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
Former [2009/26]Harding, Charles Thomas
D Young & Co 120 Holborn London
EC1N 2DY / GB
Former [2006/34]Harding, Charles Thomas
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date04773743.207.10.2004
[2006/34]
WO2004JP15205
Priority number, dateJP2003035281910.10.2003         Original published format: JP 2003352819
[2006/34]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005034994
Date:21.04.2005
Language:EN
[2005/16]
Type: A1 Application with search report 
No.:EP1693069
Date:23.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.04.2005 takes the place of the publication of the European patent application.
[2006/34]
Type: B1 Patent specification 
No.:EP1693069
Date:24.07.2013
Language:EN
[2013/30]
Search report(s)International search report - published on:JP21.04.2005
(Supplementary) European search report - dispatched on:EP04.01.2008
ClassificationIPC:C07K16/30, A61K39/395, A61P35/00, A61P35/04
[2012/32]
CPC:
C07K16/30 (EP,US); A61P35/00 (EP); A61P35/04 (EP);
C07K16/3061 (EP,US); A61K2039/505 (EP,US); C07K2317/41 (EP,US);
C07K2317/732 (EP,US) (-)
Former IPC [2006/34]A61K39/395, A61P35/00, A61P35/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/34]
TitleGerman:MITTEL ZUR BEHANDLUNG VON SOLIDEN TUMOREN[2006/34]
English:REMEDY FOR SOLID TUMOR[2006/34]
French:REMEDE PERMETTANT DE TRAITER UNE TUMEUR SOLIDE[2006/34]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase05.05.2006Translation filed 
08.05.2006National basic fee paid 
08.05.2006Search fee paid 
08.05.2006Designation fee(s) paid 
08.05.2006Examination fee paid 
Examination procedure31.03.2005Request for preliminary examination filed
International Preliminary Examining Authority: JP
08.05.2006Examination requested  [2006/34]
11.08.2006Amendment by applicant (claims and/or description)
26.03.2008Despatch of a communication from the examining division (Time limit: M06)
26.09.2008Reply to a communication from the examining division
09.07.2010Despatch of a communication from the examining division (Time limit: M06)
06.01.2011Reply to a communication from the examining division
19.09.2012Communication of intention to grant the patent
04.01.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.02.2013Communication of intention to grant the patent
13.06.2013Fee for grant paid
13.06.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.03.2008
Opposition(s)25.04.2014No opposition filed within time limit [2014/27]
Fees paidRenewal fee
12.10.2006Renewal fee patent year 03
15.10.2007Renewal fee patent year 04
13.03.2008Renewal fee patent year 05
21.10.2009Renewal fee patent year 06
27.10.2010Renewal fee patent year 07
26.10.2011Renewal fee patent year 08
15.10.2012Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.10.2004
AT24.07.2013
BE24.07.2013
BG24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
MC24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
TR24.07.2013
IE07.10.2013
LU07.10.2013
GR25.10.2013
CH31.10.2013
LI31.10.2013
PT25.11.2013
[2015/34]
Former [2015/32]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
MC24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
TR24.07.2013
IE07.10.2013
GR25.10.2013
CH31.10.2013
LI31.10.2013
PT25.11.2013
Former [2014/48]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
MC24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
IE07.10.2013
GR25.10.2013
CH31.10.2013
LI31.10.2013
PT25.11.2013
Former [2014/34]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
MC24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
GR25.10.2013
CH31.10.2013
LI31.10.2013
PT25.11.2013
Former [2014/25]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
MC24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/24]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
ES24.07.2013
FI24.07.2013
IT24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/23]AT24.07.2013
BE24.07.2013
CY24.07.2013
CZ24.07.2013
DK24.07.2013
EE24.07.2013
FI24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
SK24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/22]AT24.07.2013
BE24.07.2013
CY24.07.2013
DK24.07.2013
FI24.07.2013
NL24.07.2013
PL24.07.2013
RO24.07.2013
SE24.07.2013
SI24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/21]AT24.07.2013
BE24.07.2013
CY24.07.2013
DK24.07.2013
FI24.07.2013
NL24.07.2013
PL24.07.2013
SE24.07.2013
SI24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/18]AT24.07.2013
BE24.07.2013
CY24.07.2013
FI24.07.2013
NL24.07.2013
PL24.07.2013
SE24.07.2013
SI24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/14]CY10.07.2013
AT24.07.2013
BE24.07.2013
FI24.07.2013
NL24.07.2013
PL24.07.2013
SE24.07.2013
SI24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/12]CY10.07.2013
AT24.07.2013
BE24.07.2013
FI24.07.2013
PL24.07.2013
SE24.07.2013
SI24.07.2013
GR25.10.2013
PT25.11.2013
Former [2014/11]CY10.07.2013
AT24.07.2013
BE24.07.2013
FI24.07.2013
PL24.07.2013
SE24.07.2013
PT25.11.2013
Former [2014/10]CY10.07.2013
AT24.07.2013
BE24.07.2013
SE24.07.2013
PT25.11.2013
Former [2014/09]AT24.07.2013
BE24.07.2013
SE24.07.2013
PT25.11.2013
Former [2014/08]PT25.11.2013
Documents cited:Search[A]EP0997152  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [A] 1-7* the whole document *;
 [X]WO0175177  (US HEALTH [US], et al) [X] 1-7 * page 5, line 19 * * page 13, line 17 * * table 4 * * sequence 128 * * page 18, line 23 - page 24, line 13 * * claims 14,23,30,33 *
International search[X]JPH10155494  (CHUGAI PHARMACEUTICAL CO LTD);
 [X]WO02064159  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [XP]WO2004039398  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [X]  - OZAKI K. ET AL., "Localization and imaging of human plasmacytoma xenografts in severe combined immunodeficiency mice by a new murine monoclonal antibody", J. EXP. MED., (1996), vol. 43, pages 7 - 15, XP002912306
 [X]  - TREON S.P. ET AL., "Immunotherapeutic strategies for the treatment of plasma cell malignancies", SEMINARS IN ONCOLOGY, (2000), vol. 27, no. 5, pages 598 - 613, XP002976439
 [X]  - SHIKU H., "Kotai ryoho no jissai to kanosei", EXPERIMENTAL MEDICINE, (2002), vol. 20, no. 6, pages 841 - 845, XP002989344
Examination   - WEI WANG ET AL, "HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, (20081101), vol. 58, no. 6, ISSN 1432-0851, pages 967 - 976, XP019706329
    - WANG W ET AL, "Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells", LUNG CANCER, ELSEVIER, AMSTERDAM, NL, vol. 63, no. 1, doi:10.1016/J.LUNGCAN.2008.04.009, ISSN 0169-5002, (20090101), pages 23 - 31, (20080603), XP025800786

DOI:   http://dx.doi.org/10.1016/j.lungcan.2008.04.009
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.